Thus, given the biological effects of these variants, it would be expected that the combination of risk genotypes, in this case DD of ACE, CC of rs699 and CC of AGTR-1, confer greater likelihood of developing MetS, DM2, hypertension and cardiovascular disease. This evidence concerns the gene AGTR1 and metabolic syndrome.